What should we expect from the next generation of antiarrhythmic drugs?
about
Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.Antiarrhythmics--from cell to clinic: past, present, and future.Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.Dronedarone: an amiodarone analogue.Effects of the class III antiarrhythmic agent dofetilide (UK-68,798) on L-type calcium current from rabbit ventricular myocytes.
P2860
What should we expect from the next generation of antiarrhythmic drugs?
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
What should we expect from the next generation of antiarrhythmic drugs?
@ast
What should we expect from the next generation of antiarrhythmic drugs?
@en
What should we expect from the next generation of antiarrhythmic drugs?
@nl
type
label
What should we expect from the next generation of antiarrhythmic drugs?
@ast
What should we expect from the next generation of antiarrhythmic drugs?
@en
What should we expect from the next generation of antiarrhythmic drugs?
@nl
prefLabel
What should we expect from the next generation of antiarrhythmic drugs?
@ast
What should we expect from the next generation of antiarrhythmic drugs?
@en
What should we expect from the next generation of antiarrhythmic drugs?
@nl
P2860
P1476
What should we expect from the next generation of antiarrhythmic drugs?
@en
P2860
P304
P356
10.1111/J.1540-8167.1999.TB00676.X
P577
1999-02-01T00:00:00Z